Your Source for Venture Capital and Private Equity Financings

Select An Article

First Ascent Biomedical Secures $6M
2025-01-13
MIAMI, FL, First Ascent Biomedical, a pioneer in personalized cancer treatment, announced a $6 million investment from Vidal Duart Enterprises.
Read More
hc1 Completes $6.25 Million Funding Round
2025-01-13
INDIANAPOLIS, IN, hc1, the leader in transforming lab data into actionable intelligence, has raised $6.25M.
Read More
Qventus Announces $105 Million Series D Funding
2025-01-13
NEW YORK, NY, Qventus, a leading provider of AI-based care automation software for health systems, announced a $105 million investment led by global investment firm KKR.
Read More
Normunity Closes $75 Million Series B Financing
2025-01-13
NEW HAVEN, CT, Normunity, a biotechnology company creating novel anti-cancer therapies, announced that it has closed a Series B financing for $75 million.
Read More
Tune Therapeutics Inks Over $175M in Series B
2025-01-13
DURHAM, NC, Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing.
Read More
Red Sky Health Secures $3M in Seed Funding
2025-01-13
BOSTON, MA, Red Sky Health (RSH), an AI-driven platform designed to optimize healthcare claims management, has raised $3 million in seed funding.
Read More
Clear Labs Secures $30 Million in Series D
2025-01-13
SAN CARLOS, CA, Clear Labs, a provider of fully automated, next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has secured $30 million in its Series D financing.
Read More
Ashvattha Therapeutics Inks $50M Series B Extension
2025-01-13
REDWOOD CITY, CA, Ashvattha Therapeutics, a clinical-stage company advancing a new class of nanomedicine therapeutics, announced additional financing as an extension of its Series B of up to $50 million.
Read More